Acessibilidade / Reportar erro

Dermoscopy of the iris: identification of Lisch nodules and contribution to the diagnosis of neurofibromatosis type 1☆☆ ☆☆ Study conducted at the Dermatology Service, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.

Abstract

Neurofibromatosis is a common genodermatosis, whose diagnosis often involves the participation of a dermatologist. A case of a 38-year-old female patient with four café-au-lait macules and eleven neurofibromas on clinical examination is presented. Dermoscopy allowed the identification of Lisch nodules in the iris, bilaterally. The combination of these findings allowed the diagnosis of neurofibromatosis type 1, according to NIH criteria. Lisch nodules are melanocytic hamartomas of the iris, which must be evaluated through a visual augmentation method, usually employed in ophthalmology. Alternatively, dermoscopy can be used and contribute to the early diagnosis of neurofibromatosis type 1.

KEYWORDS
Dermoscopy; Neurocutaneous syndromes; Neurofibromatoses; Neurofibromatosis 1

Case report

A 38-year-old female patient was referred to the Dermatology Service for the evaluation of nodular lesions present since adolescence, with progressive growth. On physical examination, she had ten soft, normochromic nodules, distributed on the trunk and limbs, compatible with neurofibromas. She also had a lesion measuring 10 cm in diameter, on the back of the left thigh, compatible with a plexiform neurofibroma, and four café-au-lait macules, measuring 1 to 3 cm in diameter, distributed on the trunk. She had no axillary or inguinal freckling. She denied a history of visual or bone alterations. She reported a history of cognitive impairment, which had not been objectively assessed, and a paternal family history of similar skin lesions, without a diagnosis and no possibility of objective assessment at that time.

At this time, the patient had several findings suggestive of neurofibromatosis type 1; however, she still did not meet the diagnostic criteria of the National Institutes of Health (NIH) (Table 1).11 Ferner R, Huson S, Thomas N, Moss C, Willshaw H, Evans D, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet. 2007;44:81-8. The authors then observed that the patient had light-colored irises, with some brown spots (Fig. 1). Iris dermoscopy was performed, in which brownish-yellow nodules were observed bilaterally, compatible with Lisch nodules (Fig. 2). The combination of these clinical findings allowed the diagnosis of neurofibromatosis type 1, according to the NIH criteria. The patient was referred for multidisciplinary evaluation with the Genetics, Neurology, Ophthalmology, and Surgical teams.

Table 1
Diagnostic criteria for neurofibromatosis type 1a a Two or more of the criteria are required for diagnosis. (National Institutes of Health, 1990)

Figure 1
To the naked eye: Possible brownish-yellow spots on the iris.
Figure 2
Dermoscopy with polarized light: Lisch nodules on the iris (brownish-yellow lesions of varying hues, with wide distribution).

Discussion

The diagnosis of neurofibromatosis usually requires a multidisciplinary team, in which the role of the dermatologist is essential. It is based on the NIH clinical criteria and generally does not require genetic testing. These criteria are highly sensitive and specific, except in very young children.11 Ferner R, Huson S, Thomas N, Moss C, Willshaw H, Evans D, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet. 2007;44:81-8.,22 De Bella K, Szudek J, Friedman JM. Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics. 2000;105(Pt 1):608-14. Early diagnosis of this genodermatosis is important for the monitoring of lesions and preventing complications.

Lisch nodules are well-defined melanocytic iris hamartomas, with a dome appearance, light brown color, and do not cause any visual alterations.33 Lewis RA, Riccardi VM. Von Recklinghausen neurofibromatosis. Incidence of iris hamartomata. Ophthalmology. 1981;88:348-54.,44 Gomes Moyano E, Martínez Pilar L, Mora MRC, Garcia MVH, Fracia A, Diaz DJG, et al. Using dermoscopy to assess diagnostic criteria of neurofibromatosis. J Am Acad Dermatol. 2015;73:e17-8. They usually appear between two and six years of age and are present in more than 90% of adult patients with neurofibromatosis.33 Lewis RA, Riccardi VM. Von Recklinghausen neurofibromatosis. Incidence of iris hamartomata. Ophthalmology. 1981;88:348-54. Eventually, they may be visible to the naked eye, especially if the iris is light in color and the nodules are large and numerous, but evaluation with visual enlargement is recommended. Traditionally, ophthalmic examination with a slit lamp is performed; recently, the possibility of detection through dermoscopy has been described, including in brown eyes.44 Gomes Moyano E, Martínez Pilar L, Mora MRC, Garcia MVH, Fracia A, Diaz DJG, et al. Using dermoscopy to assess diagnostic criteria of neurofibromatosis. J Am Acad Dermatol. 2015;73:e17-8.,55 Gara S, Jones M, Litaiem N, Bacha T, Boukari M, Zeglaoui F. Dermoscopy is a useful tool for diagnosing Lisch nodules on brown eyes. Int J Dermatol. 2020;59:880-1.

The observation of Lisch nodules can be especially useful in young children with multiple café-au-lait macules and no family history of neurofibromatosis, as they appear before the neurofibromas.44 Gomes Moyano E, Martínez Pilar L, Mora MRC, Garcia MVH, Fracia A, Diaz DJG, et al. Using dermoscopy to assess diagnostic criteria of neurofibromatosis. J Am Acad Dermatol. 2015;73:e17-8. Evaluation by an ophthalmologist is indicated to differentiate them from granulomatous iritis and from iris mammillations, nevi, and iris melanoma; as well as for the diagnosis of tumors associated with neurofibromatosis, which can cause visual alterations, such as optic pathway gliomas.11 Ferner R, Huson S, Thomas N, Moss C, Willshaw H, Evans D, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet. 2007;44:81-8.,44 Gomes Moyano E, Martínez Pilar L, Mora MRC, Garcia MVH, Fracia A, Diaz DJG, et al. Using dermoscopy to assess diagnostic criteria of neurofibromatosis. J Am Acad Dermatol. 2015;73:e17-8. Additionally, the presence of Lisch nodules is characteristic of neurofibromatosis type 1, being absent in neurofibromatosis type 2.11 Ferner R, Huson S, Thomas N, Moss C, Willshaw H, Evans D, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet. 2007;44:81-8.

This is the report of an adult patient with neurofibromas and café-au-lait macules, but without a previous diagnosis, for which the observation of Lisch nodules through dermoscopy was important for the diagnosis of neurofibromatosis type 1. Therefore, the authors highlight that dermoscopy can be an auxiliary tool for the dermatologist to assess cutaneous and the ocular lesions of this genodermatosis.

  • ☆☆
    Study conducted at the Dermatology Service, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
  • Financial support
    None declared.

References

  • 1
    Ferner R, Huson S, Thomas N, Moss C, Willshaw H, Evans D, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet. 2007;44:81-8.
  • 2
    De Bella K, Szudek J, Friedman JM. Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics. 2000;105(Pt 1):608-14.
  • 3
    Lewis RA, Riccardi VM. Von Recklinghausen neurofibromatosis. Incidence of iris hamartomata. Ophthalmology. 1981;88:348-54.
  • 4
    Gomes Moyano E, Martínez Pilar L, Mora MRC, Garcia MVH, Fracia A, Diaz DJG, et al. Using dermoscopy to assess diagnostic criteria of neurofibromatosis. J Am Acad Dermatol. 2015;73:e17-8.
  • 5
    Gara S, Jones M, Litaiem N, Bacha T, Boukari M, Zeglaoui F. Dermoscopy is a useful tool for diagnosing Lisch nodules on brown eyes. Int J Dermatol. 2020;59:880-1.

Publication Dates

  • Publication in this collection
    02 Aug 2021
  • Date of issue
    May-Jun 2021

History

  • Received
    10 July 2020
  • Accepted
    25 Sept 2020
Sociedade Brasileira de Dermatologia Av. Rio Branco, 39 18. and., 20090-003 Rio de Janeiro RJ, Tel./Fax: +55 21 2253-6747 - Rio de Janeiro - RJ - Brazil
E-mail: revista@sbd.org.br